U.S. government officials have reached an agreement with Pfizer that secures 10 million courses of the drugmaker’s COVID-19 pill.
The government is paying $5.3 billion, or $529 a course for the pill.
Paxlovid, Pfizer's COVID-19 pill, is seen manufactured in Ascoli, Italy, in an undated photograph. Pfizer via Reuters
Zachary Stieber
Senior Reporter
|Updated:
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
Author’s Selected Articles
